Article citationsMore>>

Ramella, S. EdyIppolito, L.T., Ippolito, E., Fiore, M., Cellini, F., Stimato, G., Gaudino, D., Greco, C., Ramponi, S. and Cammilluzzi, E., Cesarini, C., Piermattei, A., Cesario, A. and D'Angelillo, R.M. (2012) Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment. Medical Dosimetry, 37, 186-191.
https://doi.org/10.1016/j.meddos.2011.06.010

has been cited by the following article:

• TITLE: Dosimetric Effects of a Commercial Breast Board Patient Support System

  AUTHORS: Eve Schodowski, Austin Wilkinson, Sadik Khuder, David Pearson

  KEYWORDS: Prone Breast Treatment, Breast Board, Attenuating Structure, Interfraction-al Set-Up, Patient Support System, Robustness

  JOURNAL NAME: International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, Vol.11 No.1, December 27, 2021

  ABSTRACT: Aim: In prone breast treatments, a carbon fiber support device resides under the contralateral breast. Tangent beams are designed to encompass the treated breast and these often pass through the board at a shallow angle, resulting in significant attenuation. Our planners account for this attenuation by adding field-in-field dose to the deep part of the breast, through the board. Concern was raised about how accurate the treatment delivery is when the inherent uncertainties of patients’ positions are accounted for. Furthermore, transmission measurements are usually carried out perpendicular to the board, a non-clinical situation. The goal of this study is to evaluate the dosimetric effect of the board and the robustness of the plan to positional uncertainty. Materials and Methods: Twenty-two breast patients treated on a commercial prone breast board between 2017 and 2020 were selected for this retrospective study. To evaluate the board’s attenuation, we compared the plans with the board removed from the dose calculation. To quantify the robustness of this technique, we moved the beam isocenter with respect to the patient and board. Results: Our results showed that when the breast board is removed from a plan which was designed to account for the board attenuation, the average point dose increases by 7.48%, with a maximum of 22%. Comparing results with a mixed Analysis of Variance (ANOVA) and a least-square means analysis, our robustness evaluation indicates that anterior shifts at every magnitude (1 mm through 5 mm) make a significant difference in all dose statistics (D95, max, 95% prescription coverage and homogeneity index) investigated. In/out and right/left shifts resulted in an insignificant change in dose statistics. Conclusion: Prone breast boards can add significant dosimetric uncertainty into the treatment delivery process. Accounting for plan robustness in the design of the plan is highly recommended. A prone breast board design with support moved away from the beam path is warranted.